Loading...
P11.25 Assessing electrical properties of cells as predictive marker for patient-specific TTFields response and optimal frequency
BACKGROUND: Tumor treating fields (TTFields) are currently approved for the treatment of glioblastoma multiforme (GBM, using 200 kHz), and being tested in other tumor types such as non-small cell lung cancer and brain metastases occurring in this indication (LUNAR and METIS trials, using 150 kHz). R...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796122/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.171 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|